
Heart failure is a leading cause of hospitalization zzso No major significant improvements in prognosis have been achieved for heart failure over the last several decades despite advances in disease zzso Heart failure itself represents a final common zzso for several disease entities, including hypertension and coronary artery zzso On a molecular level, certain zzso features remain common to failing zzso Among these are zzso in the zzso zzso zzso signaling zzso Recent advances in transgenic and gene therapy techniques have presented novel therapeutic strategies for management of heart failure via genetic manipulation of zzso signaling including the targeted zzso of the zzso zzso zzso or zzso In this review, we will discuss the zzso signaling changes that accompany heart failure as well as corresponding therapeutic zzso We will then review the evidence from transgenic mouse work supporting the use of zzso manipulation in the failing heart and more recent in zzso applications of gene therapy directed at reversing or preventing heart zzso 

